The most common side effects of tirzepatide include nausea (reported in 2030% of patients), diarrhea, vomiting, constipation, abdominal pain, and decreased appetite
The $100 Billion Opportunity Although Ozempic and Mounjaro were indicated for diabetes, they were both being prescribed off-label for weight loss before the weight loss brands were approved
Tirzepatide works similarly to other GLP-1 medications, such as Wegovy (an FDA-approved drug for weight loss) and Ozempic (an FDA-approved drug for type 2 diabetes)
If you prefer to plan your meals around appetite suppression, morning injection may work better
Myricetin suppresses oxidative stress-induced cell damage via both direct and indirect antioxidant action
Dieting, or natural weight loss, is linked to a decrease in glucagon-like peptide 1